This week, the FDA expanded the approval of Johnson & Johnson’s ketamine-based nasal spray, Spravato.
Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
Related Posts
James Gunn shoots down rumors about Batman’s involvement in the…
Change Healthcare says it has notified approximately 100 million Americans…
Uber and Lyft will pay drivers a combined $328 million…